Das Klinikum

Frau Dr. Julia Blievernicht

Frau Dr. Julia Blievernicht

Studienassistentin

Promovierte Biologin. SeniorCRA. Studienassistenz.

Kontakt

Telefonnummer: 07071 29-85287

Faxnummer: 07071 29-5896

E-Mail-Adresse: julia.blievernicht@med.uni-tuebingen.de

Klinik / Institut / Zentrum

  • Jul 2025Studienassistentin am Institut für Allgemeinmedizin
  • Dez 2024Selbstständige Beratung Praxen
  • Jan 2008 - Mär 2024SeniorCRA, Parexel International GmbH
  • 1999-2008Diplom und Promotion Biologie/Biochemie
  • Hofmann Mh, Blievernicht Jk, Klein K, Saussele T, Schaeffeler E,Schwab M, Zanger Um.Aberrant Splicing Caused By Single Nucleotide PolymorphismC.516g>T [Q172h], A Marker Of CYP2B6*6 And Increased EfavirenzPlasma Concentration In HIV Patients. Jpet, 2008; 325:284-292
  • Zanger Um, Klein K, Saussele T, Blievernicht J, Hofmann Mh, SchwabM. Polymorphic Cyp2b6: Molecular Mechanisms And EmergingClinical Significance. Pharmacogenomics 2007; 8(7): 743 -59.Review.
  • Desta Z, Saussele T, Ward B, Blievernicht J, Li L, Klein K, FlockhartDa, Zanger Um. Impact Of CYP2B6 Polymorphism On HepaticEfavirenz Metabolism In Vitro. Pharmacogenomics 2007; 8(6): 547 -558.
  • Saussele T, Burk O, Blievernicht Jk, Klein K, Nüssler A, Nüssler N,Hengstler Jg, Eichelbaum M, Schwab M, Zanger Um. SelectiveInduction Of Human Hepatic Cytochromes P450 2B6 And 3A4 ByMetamizole. Clinical Pharmacology And Therapeutics., 2007; 82(3):265-74.
  • Rotger M, Tegude H, Colombo S, Cavassini M, Furrer H, Décosterd L,Blievernicht J, Saussele T, Günthard Hf, Schwab M, Eichelbaum M,Telenti A, Zanger Um And The Swiss Cohort Study: Predictive ValueOf Known And Novel Alleles Of CYP2B6 For Efavirenz PlasmaConcentrations In Hiv-Infected Individuals. Clinical PharmacologyAnd Therapeutics 2007; 81(4): 557-66.
  • Blievernicht Jk, Schaeffeler E, Klein K, Eichelbaum M, Schwab M,Zanger Um: Maldi-Tof Mass Spectrometry For Multiplex GenotypingOf CYP2B6 Single Nucleotide Polymorphisms. Clinical Chemistry2007; 53:1, 24-33.
  • Loboz Kk, Gross As, Williams Km, Liauw Ws, Day Ro, BlievernichtJk, Zanger Um, Mclachlan Aj: Cytochrome P450 2B6 Activity AsMeasured By Bupropion Hydroxylation: Effect Of Induction By5Rifampin And Ethnicity. Clinical Pharmacology And Therapeutics2006; 80(1): 75-84.
  • oscano C, Klein K, Blievernicht J, Schaeffeler E, Saussele T,Raimundo S, Eichelbaum M, Schwab M, Zanger Um: ImpairedExpression Of CYP2D6 In Intermediate Metabolizers Carrying The *41Allele Caused By The Intronic Snp 2988g>A: Evidence For ModulationOf Splicing Events. Pharmacogenetics And Genomics 2006, 16:755 -766.
  • Zanger Um, Klein K, Saussele T, Blievernicht J, Hofmann Mh, SchwabM. Polymorphic CYP2B6: Molecular Mechanisms And EmergingClinical Significance. Pharmacogenomics 2007; 8(7): 743 -59.Review.